VENUS REMEDIES
|
VENUS REMEDIES Last 5 Year Balance Sheet History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
EQUITY AND LIABILITIES | |||||
Share Capital | ₹13 Cr | ₹13 Cr | ₹13 Cr | ₹12 Cr | ₹12 Cr |
Equity - Authorised | ₹20 Cr | ₹20 Cr | ₹20 Cr | ₹20 Cr | ₹20 Cr |
Equity - Issued | ₹13 Cr | ₹13 Cr | ₹13 Cr | ₹12 Cr | ₹12 Cr |
Equity Paid Up | ₹13 Cr | ₹13 Cr | ₹13 Cr | ₹12 Cr | ₹12 Cr |
Equity Shares Forfeited | - | - | - | - | - |
Adjustments to Equity | - | - | - | - | - |
Preference Capital Paid Up | - | - | - | - | - |
Face Value | ₹10.00 | ₹10.00 | ₹10.00 | ₹10.00 | ₹10.00 |
Share Warrants & Outstandings | - | - | - | ₹14 Cr | - |
Total Reserves | ₹474 Cr | ₹447 Cr | ₹427 Cr | ₹374 Cr | ₹311 Cr |
Securities Premium | ₹88 Cr | ₹88 Cr | ₹88 Cr | ₹76 Cr | ₹76 Cr |
Capital Reserves | - | - | - | - | - |
Profit & Loss Account Balance | ₹170 Cr | ₹142 Cr | ₹116 Cr | ₹75 Cr | ₹13 Cr |
General Reserves | ₹211 Cr | ₹211 Cr | ₹211 Cr | ₹211 Cr | ₹211 Cr |
Other Reserves | ₹3.96 Cr | ₹5.05 Cr | ₹11 Cr | ₹12 Cr | ₹11 Cr |
Reserve excluding Revaluation Reserve | ₹474 Cr | ₹447 Cr | ₹427 Cr | ₹374 Cr | ₹311 Cr |
Revaluation reserve | - | - | - | - | - |
Shareholder's Funds | ₹488 Cr | ₹460 Cr | ₹440 Cr | ₹400 Cr | ₹323 Cr |
Minority Interest | - | - | - | - | - |
Long-Term Borrowings | - | - | - | - | - |
Secured Loans | - | - | - | ₹0.09 Cr | ₹24 Cr |
Non Convertible Debentures | - | - | - | - | - |
Converible Debentures & Bonds | - | - | - | - | - |
Packing Credit - Bank | - | - | - | - | - |
Inter Corporate & Security Deposit | - | - | - | - | - |
Term Loans - Banks | - | - | - | ₹0.09 Cr | ₹24 Cr |
Term Loans - Institutions | - | - | - | - | - |
Other Secured | - | - | - | - | - |
Unsecured Loans | ₹39 Cr | ₹39 Cr | ₹39 Cr | ₹47 Cr | ₹48 Cr |
Fixed Deposits - Public | - | - | - | - | - |
Loans and advances from subsidiaries | - | - | - | - | - |
Inter Corporate Deposits (Unsecured) | - | - | - | - | - |
Foreign Currency Convertible Notes | ₹39 Cr | ₹39 Cr | ₹39 Cr | ₹39 Cr | ₹39 Cr |
Long Term Loan in Foreign Currency | - | - | - | - | - |
Loans - Banks | - | - | - | - | - |
Loans - Govt. | - | - | - | - | - |
Loans - Others | - | - | - | ₹8.06 Cr | ₹9.19 Cr |
Other Unsecured Loan | - | - | - | - | - |
Deferred Tax Assets / Liabilities | ₹11 Cr | ₹11 Cr | ₹-0.68 Cr | ₹3.63 Cr | ₹17 Cr |
Deferred Tax Assets | ₹6.82 Cr | ₹10 Cr | ₹27 Cr | ₹28 Cr | ₹15 Cr |
Deferred Tax Liability | ₹18 Cr | ₹21 Cr | ₹26 Cr | ₹32 Cr | ₹31 Cr |
Other Long Term Liabilities | - | - | - | ₹0.28 Cr | ₹0.29 Cr |
Long Term Trade Payables | - | - | - | - | - |
Long Term Provisions | ₹10 Cr | ₹8.85 Cr | ₹7.95 Cr | ₹7.38 Cr | ₹6.63 Cr |
Total Non-Current Liabilities | ₹60 Cr | ₹58 Cr | ₹46 Cr | ₹58 Cr | ₹96 Cr |
Current Liabilities | - | - | - | - | - |
Trade Payables | ₹44 Cr | ₹51 Cr | ₹50 Cr | ₹71 Cr | ₹37 Cr |
Sundry Creditors | ₹44 Cr | ₹51 Cr | ₹50 Cr | ₹71 Cr | ₹37 Cr |
Acceptances | - | - | - | - | - |
Due to Subsidiaries- Trade Payables | - | - | - | - | - |
Other Current Liabilities | ₹32 Cr | ₹27 Cr | ₹38 Cr | ₹21 Cr | ₹102 Cr |
Bank Overdraft / Short term credit | - | - | - | - | - |
Advances received from customers | ₹4.76 Cr | ₹5.52 Cr | ₹12 Cr | ₹3.19 Cr | ₹6.00 Cr |
Interest Accrued But Not Due | - | - | - | - | ₹23 Cr |
Share Application Money | - | - | - | - | - |
Current maturity of Debentures & Bonds | - | - | - | - | - |
Current maturity - Others | - | - | - | - | - |
Other Liabilities | ₹27 Cr | ₹22 Cr | ₹26 Cr | ₹18 Cr | ₹73 Cr |
Short Term Borrowings | ₹2.65 Cr | ₹3.61 Cr | ₹4.06 Cr | ₹4.31 Cr | ₹86 Cr |
Secured ST Loans repayable on Demands | ₹2.65 Cr | ₹3.61 Cr | ₹4.06 Cr | ₹4.31 Cr | ₹86 Cr |
Working Capital Loans- Sec | ₹2.65 Cr | ₹3.61 Cr | ₹4.06 Cr | ₹4.31 Cr | ₹86 Cr |
Buyers Credits - Unsec | - | - | - | - | - |
Commercial Borrowings- Unsec | - | - | - | - | - |
Other Unsecured Loans | ₹-2.65 Cr | ₹-3.61 Cr | ₹-4.06 Cr | ₹-4.31 Cr | ₹-86 Cr |
Short Term Provisions | ₹1.05 Cr | ₹0.89 Cr | ₹0.75 Cr | ₹0.68 Cr | ₹0.61 Cr |
Proposed Equity Dividend | - | - | - | - | - |
Provision for Corporate Dividend Tax | - | - | - | - | - |
Provision for Tax | - | - | - | - | - |
Provision for post retirement benefits | - | - | - | - | - |
Preference Dividend | - | - | - | - | - |
Other Provisions | ₹1.05 Cr | ₹0.89 Cr | ₹0.75 Cr | ₹0.68 Cr | ₹0.61 Cr |
Total Current Liabilities | ₹79 Cr | ₹83 Cr | ₹93 Cr | ₹97 Cr | ₹225 Cr |
Total Liabilities | ₹627 Cr | ₹601 Cr | ₹579 Cr | ₹556 Cr | ₹644 Cr |
ASSETS | |||||
Gross Block | ₹618 Cr | ₹604 Cr | ₹613 Cr | ₹616 Cr | ₹624 Cr |
Less: Accumulated Depreciation | ₹399 Cr | ₹388 Cr | ₹372 Cr | ₹355 Cr | ₹335 Cr |
Less: Impairment of Assets | - | - | - | - | - |
Net Block | ₹219 Cr | ₹216 Cr | ₹241 Cr | ₹262 Cr | ₹289 Cr |
Lease Adjustment A/c | - | - | - | - | - |
Capital Work in Progress | ₹21 Cr | ₹26 Cr | ₹25 Cr | ₹25 Cr | ₹25 Cr |
Non Current Investments | ₹0.02 Cr | - | - | - | - |
Long Term Investment | ₹0.02 Cr | - | - | - | - |
Quoted | - | - | - | - | - |
Unquoted | ₹0.02 Cr | - | - | - | - |
Long Term Loans & Advances | ₹23 Cr | ₹34 Cr | ₹33 Cr | ₹35 Cr | ₹36 Cr |
Other Non Current Assets | ₹4.50 Cr | ₹2.23 Cr | ₹1.57 Cr | - | - |
Total Non-Current Assets | ₹267 Cr | ₹278 Cr | ₹301 Cr | ₹322 Cr | ₹350 Cr |
Current Assets Loans & Advances | - | - | - | - | - |
Currents Investments | ₹19 Cr | ₹20 Cr | - | - | - |
Quoted | ₹19 Cr | ₹20 Cr | - | - | - |
Unquoted | - | - | - | - | - |
Inventories | ₹122 Cr | ₹120 Cr | ₹126 Cr | ₹120 Cr | ₹141 Cr |
Raw Materials | ₹75 Cr | ₹78 Cr | ₹75 Cr | ₹66 Cr | ₹86 Cr |
Work-in Progress | ₹20 Cr | ₹25 Cr | ₹34 Cr | ₹37 Cr | ₹33 Cr |
Finished Goods | ₹22 Cr | ₹12 Cr | ₹16 Cr | ₹17 Cr | ₹18 Cr |
Packing Materials | - | - | - | - | - |
Stores  and Spare | - | - | - | - | - |
Other Inventory | ₹4.41 Cr | ₹5.50 Cr | ₹0.14 Cr | ₹0.37 Cr | ₹4.36 Cr |
Sundry Debtors | ₹80 Cr | ₹77 Cr | ₹39 Cr | ₹32 Cr | ₹31 Cr |
Debtors more than Six months | ₹2.15 Cr | ₹3.05 Cr | ₹1.73 Cr | ₹1.42 Cr | - |
Debtors Others | ₹78 Cr | ₹74 Cr | ₹37 Cr | ₹31 Cr | ₹31 Cr |
Cash and Bank | ₹68 Cr | ₹54 Cr | ₹50 Cr | ₹31 Cr | ₹2.13 Cr |
Cash in hand | ₹0.15 Cr | ₹0.16 Cr | ₹0.08 Cr | ₹0.05 Cr | ₹1.51 Cr |
Balances at Bank | ₹68 Cr | ₹54 Cr | ₹50 Cr | ₹31 Cr | ₹0.61 Cr |
Other cash and bank balances | - | - | - | - | - |
Other Current Assets | ₹1.32 Cr | ₹1.78 Cr | ₹5.01 Cr | ₹5.70 Cr | ₹56 Cr |
Interest accrued on Investments | - | - | - | - | - |
Interest accrued on Debentures | - | - | - | - | - |
Deposits with Government | - | - | - | - | - |
Interest accrued and or due on loans | - | - | - | - | - |
Prepaid Expenses | ₹0.63 Cr | ₹0.67 Cr | ₹0.50 Cr | ₹0.50 Cr | ₹0.30 Cr |
Other current_assets | ₹0.69 Cr | ₹1.11 Cr | ₹4.51 Cr | ₹5.20 Cr | ₹55 Cr |
Short Term Loans and Advances | ₹69 Cr | ₹50 Cr | ₹58 Cr | ₹45 Cr | ₹64 Cr |
Advances recoverable in cash or in kind | ₹2.31 Cr | ₹3.14 Cr | ₹2.91 Cr | ₹2.25 Cr | ₹18 Cr |
Advance income tax and TDS | ₹37 Cr | ₹32 Cr | ₹30 Cr | ₹29 Cr | ₹29 Cr |
Amounts due from directors | - | - | - | - | - |
Due From Subsidiaries | - | - | - | - | - |
Inter corporate deposits | - | - | - | - | - |
Corporate Deposits | - | - | - | - | - |
Other Loans & Advances | ₹30 Cr | ₹15 Cr | ₹26 Cr | ₹14 Cr | ₹18 Cr |
Total Current Assets | ₹360 Cr | ₹323 Cr | ₹278 Cr | ₹234 Cr | ₹294 Cr |
Net Current Assets (Including Current Investments) | ₹280 Cr | ₹240 Cr | ₹185 Cr | ₹137 Cr | ₹69 Cr |
Miscellaneous Expenses not written off | - | - | - | - | - |
Total Assets | ₹627 Cr | ₹601 Cr | ₹579 Cr | ₹556 Cr | ₹644 Cr |
Contingent Liabilities | ₹37 Cr | ₹40 Cr | ₹11 Cr | ₹0.16 Cr | ₹0.16 Cr |
Total Debt | ₹41 Cr | ₹42 Cr | ₹43 Cr | ₹51 Cr | ₹220 Cr |
Book Value | 364.74 | 344.38 | 329.50 | 313.18 | 262.01 |
Adjusted Book Value | 364.74 | 344.38 | 329.50 | 313.18 | 262.01 |
Compare Balance Sheet of peers of VENUS REMEDIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
VENUS REMEDIES | ₹391.3 Cr | -3.2% | -10.4% | -12.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹431,352.0 Cr | 1.7% | -4.7% | 48.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹159,265.0 Cr | 4.4% | 3.1% | 66% | Stock Analytics | |
CIPLA | ₹120,035.0 Cr | -0.9% | -1.7% | 17.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,286.0 Cr | -1% | -8.9% | 6.5% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹95,461.4 Cr | -1% | -4% | 48.4% | Stock Analytics |
VENUS REMEDIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
VENUS REMEDIES | -3.2% |
-10.4% |
-12.7% |
SENSEX | 1.8% |
-2.5% |
19.9% |
You may also like the below Video Courses